Research Funded To Date

Since inception $91 million invested in a cure for brain cancer

2019

NATIONAL GLIOBLASTOMA AWARNESS DAY, JULY 18, 2019, MATCHING DONATION FOR THE IVY BRAIN TUMOR CENTER.

PIs: Nader Sanai, M.D., FAANS, FACS
Director, Division of Neurosurgical Oncology
Director, Barrow Brain Tumor Research Center
Barrow Neurological Institute
NeuroTrials, LLC

Award: $250,000

RIBOCICLIB PLUS EVEROLIMUS PHASE 0/2 CLINICAL TRIAL FOR RECURRENT GLIOBLASTOMAS.

PIs: Nader Sanai, M.D., FAANS, FACS
Director, Division of Neurosurgical Oncology
Director, Barrow Brain Tumor Research Center
Barrow Neurological InstituteZ
NeuroTrials, LLC

Award: $325,000

UCSF PRECLINICAL CORE FOR DRUG DEVELOPMENT AT THE IVY BRAIN TUMOR CENTER.

PIs: Nader Sanai, M.D., FAANS, FACS
Director, Division of Neurosurgical Oncology
Director, Barrow Brain Tumor Research Center
Barrow Neurological Institute
NeuroTrials, LLC

Nicholas Butowski, M.D.
Professor Neurological Surgery
Director Translational Research Neuro-Oncology
Director UCNS Fellowship Neuro-Oncology
Chair, CNS Tumors Site Committee UCSF Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco

Award: $715,000

DEVELOPMENT OF TRIPLE-DRUG COCKTAILS TO INDUCE GLIOBLASTOMA AUTOPHAGY.

PIs: Nader Sanai, M.D., FAANS, FACS
Director, Division of Neurosurgical Oncology
Director, Barrow Brain Tumor Research Center
Barrow Neurological Institute
NeuroTrials, LLC

Douglas Hanahan, Ph.D.
Professor, Ecole Polytechnique Fédérale de Lausanne
Director, Laboratory of Translational Oncology
Swiss Institute for Experimental Cancer Research/Swiss Federal Institute of Technology

Award: $270,000 over eighteen months

DAMON RUNYON CLINICAL INVESTIGATOR AWARD FUNDING RESEARCH FOR EARLY CAREER MD’S AND MD/PHDS. RESEARCH PROJECT FUNDED IS THE INVESTIGATION OF A BIOMARKR PHASE 2 STUDY TO EVALUATE TARGETED THERAPY HARBORING SPECIFIC GENETIC ALTERATIONS.

PI:  Priscilla K. Brastianos, MD
Clinical Investigator
Massachusetts General Hospital
Damon Runyon Cancer Research Foundation

Award: $200,000

NEUROLOGICAL SCIENCES INTERNSHIP PROGRAM AT TGEN DESIGNED TO GIVE HIGH SCHOOL AND UNDERGRADUATE STUDENTS INTENSIVE, HANDS-ON RESEARCH EXPERIENCE WORKING ALONGSIDE A MENTOR-SCIENTIST TO LEARN ABOUT TRANSLATIONAL RESEARCH WHILE INVESTIGATING QUESTIONS WITHIN THE NEUROLOGICAL SCIENCES.

PI: Julie Euber
Manager of Education and Outreach
Translational Genomics Research Institute (TGen)

Award: $122,274

IMAGING TUMOR METABOLISM IN GBM PATIENTS TO HELP OPTIMIZE ANTI-TUMOR THERAPIES. THE ABILITY TO MONITOR PKM2, A KEY REGULATOR OF GBM METABOLISM, ALLOWS POTENTIAL MONITORING ESSENTIAL TO EARLY THERAPY RESPONSE.

PI: Sanjiv Sam Gambhir M.D., Ph.D.
Chair, Department of Radiology
Director, Molecular Imaging Program at Stanford
Director, Canary Center at Stanford for Cancer Early Detection
Stanford University School of Medicine

Award: $3,004,560 over three years
BACK TO TOP
Close Menu